Evidence map›Paper›PMID 42493210›Full record

ArticleBMJ open2026

Dutch-TIMELINESS: optimising choledocholithiasis treatment in the Netherlands - protocol of a national implementation project.

Anne J J The, Maud M T Merks, Robert C Verdonk, Lucas Goense, Max H G van Maasakkers, Peter J van der Schaar, Peter van Duijvendijk, Niels G Venneman, Mike S L Liem, Jan P Deroose and 4 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Anne J J TheDepartment of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands a.the@antoniusziekenhuis.nl.ORCID http://orcid.org/0009-0008-5231-2256
Maud M T MerksDepartment of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
Robert C VerdonkDepartment of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, The Netherlands.
Lucas GoenseDepartment of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
Max H G van MaasakkersDepartment of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.ORCID http://orcid.org/0009-0003-6731-7205
Peter J van der SchaarDepartment of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, The Netherlands.
Peter van DuijvendijkDepartment of Surgery, Gelre Ziekenhuizen, Apeldoorn, The Netherlands.
Niels G VennemanDepartment of Gastroenterology & Hepatology, Medisch Spectrum Twente, Enschede, The Netherlands.
Mike S L LiemDepartment of Surgery, Medisch Spectrum Twente, Enschede, The Netherlands.
Jan P DerooseDepartment of Surgery, Martini Hospital, Groningen, The Netherlands.
Willem J ThijsDepartment of Gastroenterology & Hepatology, Martini Hospital, Groningen, The Netherlands.
Lea M DijksmanDepartment of Research and Development, St Antonius Hospital, Nieuwegein, The Netherlands.ORCID http://orcid.org/0000-0001-9227-1390
Djamila BoermaDepartment of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.
Teus J WeijsDepartment of Surgery, St Antonius Hospital, Nieuwegein, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe Dutch guideline 'Gallstone disease' (2016) recommends performing a cholecystectomy within 72 hours following endoscopic retrograde cholangiopancreatography (ERCP) for common bile duct stones to prevent recurrent gallstone-related complications. Nevertheless, guideline adherence in the Netherlands remains low, and the time between ERCP and cholecystectomy often exceeds 72 hours. Our project aims to improve national guideline adherence to 85% or higher and thereby reduce the incidence of gallstone-related complications after ERCP. METHODS AND ANALYSIS: The Dutch-TIMELINESS is a multicentre implementation project using a Multiphase Optimisation Strategy. The project includes 61 Dutch hospitals. In phase 1, all patients undergoing ERCP for choledocholithiasis from 1 January to 31 March 2023 will be analysed to serve as a benchmark. In phase 2, each hospital develops and implements its own tailored protocol in line with the guideline, guided by the benchmark data. In phase 3, from 1 December 2025 to 31 March 2026, the new protocols will be prospectively evaluated with real-time monitoring and refined as necessary. Statistical methods are predefined in the protocol. ETHICS AND DISSEMINATION: The Medical Research Ethics Committees United reviewed the protocol and concluded it does not fall under the scope of the Medical Research Involving Human Subjects Act (WMO). Local institutional research departments and the board of directors reviewed and approved the protocol in all participating hospitals. Results will be published in international peer-reviewed scientific journals and presented at national conferences.

Indexed as

Cholangiopancreatography, Endoscopic RetrogradeCholecystectomyCholedocholithiasisGuideline AdherenceClinical ProtocolsHumansNetherlandsPostoperative ComplicationsPractice Guidelines as TopicResearch DesignTime FactorsClinical ProtocolsEndoscopyGASTROENTEROLOGYHepatobiliary diseaseSURGERY

Identifiers

PMID42493210
PMCPMC13404623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.